Market Cap 229.84M
Revenue (ttm) 0.00
Net Income (ttm) -30.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 387,600
Avg Vol 724,422
Day's Range N/A - N/A
Shares Out 65.86M
Stochastic %K 1%
Beta 0.35
Analysts Hold
Price Target $11.00

Company Profile

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and dev...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 620 3186
Address:
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, United States
coba4444
coba4444 Jul. 31 at 11:22 PM
$GALT My own brother ask me "What is going on with that shitty stock?" I have to muster some enthusiasm and try to explain its the illegal shorts etc etc and the science is good. Its embarassing. 9 years and I am even
0 · Reply
Matolemeu
Matolemeu Jul. 31 at 10:30 PM
$GALT ain't not thang. Ya prayed for a discount. Here it is
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 31 at 10:03 PM
$GALT remember galecticans 8.7 weeks remaining in Q3 (which ends on September 30, 2026). This breaks down to 61 days left in the quarter. Worry not about the daily fluctuations, news cometh soon....
1 · Reply
SamGantVHee
SamGantVHee Jul. 31 at 9:55 PM
$GALT let's see if multi month support line (orange) holds, if so high $2.80's/low $2.90's should be the bottom. Short term downtrend line (red) meets with this support line next Tuesday, August 4th. If it does hold and continues to consolidate without news, this support line meets the long term downtrend line end of the year. If it doesn't hold, $2.20's will be in play according to multi year support line (black) RSI: daily (36), weekly (46), monthly (50) -> technically oversold, but has room to be pushed further lower. Need news sooner rather than later or else this will likely continue to bleed as impatient/scared retail continues to sell. Holding and preparing funds to start adding on a weekly basis, as long as this is in the $2's. GLTA
1 · Reply
Rocket22fb
Rocket22fb Jul. 31 at 9:52 PM
$GALT Funny how the same people saying "share price doesn't matter" are also the ones telling people not to lend their shares, bitching when people sell, celebrating green days, and posting nonstop to encourage buying. All behaviors about influencing or protecting the share price. If the share price doesn't matter, none of that would matter either. So which is it? Either share price matters, or all the pumping, anti-selling posts, and outrage over lending shares are pointless. You can't have it both ways.
0 · Reply
ThomasLD
ThomasLD Jul. 31 at 8:50 PM
$GALT Recommend to ignore this stock until next June, 2027. Let the management do their jobs until this company gets sold to a BP. We know that we have good science. Don’t let the stock price and naked shorts to kill you every day. GLTA!
2 · Reply
dubstep
dubstep Jul. 31 at 8:14 PM
$GALT Welp, that was a terrible week. At this point, all we can do is hope management provides something: • News • An update • Direction • A meaningful PR As the share price continues to slide, the one thing we can’t afford is more silence. Which is what we will likely get :( A question for everyone on this board: Why do you think the stock keeps dropping, and why does the market seem to have so little interest right now? I’m genuinely surprised. Based on where GALT is in the regulatory process, I would have expected a much stronger valuation. Clearly, the market is not pricing this company like a Phase 3 story. Is the market that spooked by the dilution and the convertibles? (I figured becasue it was delayed till a likely buy out the convertibles didn’t matter but I guess clearly they do.) Is the science mid? Is the biotech space not as hot or slowing down BP already went shopping? We have lost almost all the gains Any ideas the casue? Can’t just be shorts right
1 · Reply
Bobear12
Bobear12 Jul. 31 at 8:04 PM
$GALT ASH I use to get excited about the Monday morning opening now I dread it. Bo
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 31 at 8:02 PM
$GALT news pre market on Monday would be nice start to the month and icing on the cake!
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 31 at 7:59 PM
$GALT like I said sub 3 close...$GALT stay tuned
1 · Reply
Latest News on GALT
Galectin Therapeutics presents belapectin data at EASL 2026

2026-05-27T15:47:04.000Z - 2 months ago

Galectin Therapeutics presents belapectin data at EASL 2026


Galectin Therapeutics Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

Galectin Therapeutics Quarterly report: Q1 2026


Galectin Therapeutics Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

Galectin Therapeutics Earnings release: Q1 2026


Galectin Therapeutics publishes NAVIGATE Phase 2b trial results

2026-05-11T20:22:35.000Z - 2 months ago

Galectin Therapeutics publishes NAVIGATE Phase 2b trial results


Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm

Apr 27, 2026, 9:00 AM EDT - 3 months ago

Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm


Galectin Therapeutics files $200M mixed securities shelf

2026-03-31T20:17:36.000Z - 4 months ago

Galectin Therapeutics files $200M mixed securities shelf


Galectin Therapeutics Earnings release: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 4 months ago

Galectin Therapeutics Earnings release: Q4 2025


Galectin Therapeutics Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 4 months ago

Galectin Therapeutics Annual report: Q4 2025


Galectin Therapeutics appoints Henry Brem to board of directors

2026-03-17T12:15:29.000Z - 4 months ago

Galectin Therapeutics appoints Henry Brem to board of directors


Galectin Therapeutics Transcript: KOL event

Mar 10, 2026, 12:00 PM EDT - 5 months ago

Galectin Therapeutics Transcript: KOL event


Galectin Therapeutics Slides: Corporate presentation

Dec 5, 2025, 6:00 AM EST - 8 months ago

Galectin Therapeutics Slides: Corporate presentation


Galectin Therapeutics Transcript: AGM 2025

Dec 3, 2025, 11:00 AM EST - 8 months ago

Galectin Therapeutics Transcript: AGM 2025


Galectin Therapeutics reports Q4 EPS (13c) vs (18c) last year

2025-11-14T13:10:43.000Z - 9 months ago

Galectin Therapeutics reports Q4 EPS (13c) vs (18c) last year


Galectin Therapeutics Earnings release: Q3 2025

Nov 14, 2025, 8:00 AM EST - 9 months ago

Galectin Therapeutics Earnings release: Q3 2025


Galectin Therapeutics Quarterly report: Q3 2025

Nov 14, 2025, 8:00 AM EST - 9 months ago

Galectin Therapeutics Quarterly report: Q3 2025


Galectin Therapeutics presents NAVIGATE trial results at AASLD

2025-11-10T13:32:14.000Z - 9 months ago

Galectin Therapeutics presents NAVIGATE trial results at AASLD


Galectin Therapeutics Proxy statement: Proxy Filing

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Proxy statement: Proxy Filing

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Slides: Corporate Presentation

Sep 7, 2025, 6:00 PM EDT - 11 months ago

Galectin Therapeutics Slides: Corporate Presentation


Galectin Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Galectin Therapeutics Earnings release: Q2 2025


Galectin Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Galectin Therapeutics Quarterly report: Q2 2025


Galectin Therapeutics assumed with a Buy at H.C. Wainwright

2025-06-17T10:05:08.000Z - 1 year ago

Galectin Therapeutics assumed with a Buy at H.C. Wainwright


Galectin Therapeutics Transcript: Study Result

Jun 16, 2025, 12:00 PM EDT - 1 year ago

Galectin Therapeutics Transcript: Study Result


Galectin Therapeutics Press release: Study Result

Jun 16, 2025, 12:00 PM EDT - 1 year ago

Galectin Therapeutics Press release: Study Result


Galectin Therapeutics Slides: Study Result

Jun 16, 2025, 12:00 PM EDT - 1 year ago

Galectin Therapeutics Slides: Study Result


Galectin Therapeutics Earnings release: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Galectin Therapeutics Earnings release: Q1 2025


Galectin Therapeutics Quarterly report: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Galectin Therapeutics Quarterly report: Q1 2025


Galectin Therapeutics Annual report: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Galectin Therapeutics Annual report: Q4 2024


Galectin Therapeutics Earnings release: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Galectin Therapeutics Earnings release: Q4 2024


Galectin Therapeutics Proxy statement: Proxy Filing

Dec 3, 2024, 7:00 AM EST - 1 year ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Proxy statement: Proxy Filing

Dec 3, 2024, 7:00 AM EST - 1 year ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 7:30 AM EST - 1 year ago

Galectin Therapeutics Earnings release: Q3 2024


Galectin Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 7:30 AM EST - 1 year ago

Galectin Therapeutics Quarterly report: Q3 2024


Galectin Therapeutics Quarterly report: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Galectin Therapeutics Quarterly report: Q2 2024


Galectin Therapeutics Earnings release: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Galectin Therapeutics Earnings release: Q2 2024


Galectin Therapeutics Quarterly report: Q1 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

Galectin Therapeutics Quarterly report: Q1 2024


Galectin Therapeutics Earnings release: Q1 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

Galectin Therapeutics Earnings release: Q1 2024


Galectin Therapeutics Earnings release: Q4 2023

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Galectin Therapeutics Earnings release: Q4 2023


Galectin Therapeutics Annual report: Q4 2023

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Galectin Therapeutics Annual report: Q4 2023


Galectin Therapeutics Quarterly report: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

Galectin Therapeutics Quarterly report: Q3 2023


Galectin Therapeutics Earnings release: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

Galectin Therapeutics Earnings release: Q3 2023


Galectin Therapeutics Proxy statement: Proxy Filing

Oct 6, 2023, 8:00 AM EDT - 3 years ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Proxy statement: Proxy Filing

Oct 6, 2023, 8:00 AM EDT - 3 years ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Quarterly report: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Galectin Therapeutics Quarterly report: Q2 2023


Galectin Therapeutics Earnings release: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Galectin Therapeutics Earnings release: Q2 2023


Galectin Therapeutics Quarterly report: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Galectin Therapeutics Quarterly report: Q1 2023


Galectin Therapeutics Earnings release: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Galectin Therapeutics Earnings release: Q1 2023


Galectin Therapeutics Earnings release: Q4 2022

Mar 30, 2023, 7:00 AM EDT - 3 years ago

Galectin Therapeutics Earnings release: Q4 2022


Galectin Therapeutics Annual report: Q4 2022

Mar 30, 2023, 7:00 AM EDT - 3 years ago

Galectin Therapeutics Annual report: Q4 2022


Galectin Therapeutics Quarterly report: Q3 2022

Nov 14, 2022, 7:00 AM EST - 4 years ago

Galectin Therapeutics Quarterly report: Q3 2022


Galectin Therapeutics Earnings release: Q3 2022

Nov 14, 2022, 7:00 AM EST - 4 years ago

Galectin Therapeutics Earnings release: Q3 2022


Galectin Therapeutics Proxy statement: Proxy Filing

Oct 17, 2022, 8:00 AM EDT - 4 years ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics Proxy statement: Proxy Filing

Oct 17, 2022, 8:00 AM EDT - 4 years ago

Galectin Therapeutics Proxy statement: Proxy Filing


Galectin Therapeutics to Present in Upcoming Conferences

Oct 14, 2022, 8:00 AM EDT - 4 years ago

Galectin Therapeutics to Present in Upcoming Conferences


coba4444
coba4444 Jul. 31 at 11:22 PM
$GALT My own brother ask me "What is going on with that shitty stock?" I have to muster some enthusiasm and try to explain its the illegal shorts etc etc and the science is good. Its embarassing. 9 years and I am even
0 · Reply
Matolemeu
Matolemeu Jul. 31 at 10:30 PM
$GALT ain't not thang. Ya prayed for a discount. Here it is
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 31 at 10:03 PM
$GALT remember galecticans 8.7 weeks remaining in Q3 (which ends on September 30, 2026). This breaks down to 61 days left in the quarter. Worry not about the daily fluctuations, news cometh soon....
1 · Reply
SamGantVHee
SamGantVHee Jul. 31 at 9:55 PM
$GALT let's see if multi month support line (orange) holds, if so high $2.80's/low $2.90's should be the bottom. Short term downtrend line (red) meets with this support line next Tuesday, August 4th. If it does hold and continues to consolidate without news, this support line meets the long term downtrend line end of the year. If it doesn't hold, $2.20's will be in play according to multi year support line (black) RSI: daily (36), weekly (46), monthly (50) -> technically oversold, but has room to be pushed further lower. Need news sooner rather than later or else this will likely continue to bleed as impatient/scared retail continues to sell. Holding and preparing funds to start adding on a weekly basis, as long as this is in the $2's. GLTA
1 · Reply
Rocket22fb
Rocket22fb Jul. 31 at 9:52 PM
$GALT Funny how the same people saying "share price doesn't matter" are also the ones telling people not to lend their shares, bitching when people sell, celebrating green days, and posting nonstop to encourage buying. All behaviors about influencing or protecting the share price. If the share price doesn't matter, none of that would matter either. So which is it? Either share price matters, or all the pumping, anti-selling posts, and outrage over lending shares are pointless. You can't have it both ways.
0 · Reply
ThomasLD
ThomasLD Jul. 31 at 8:50 PM
$GALT Recommend to ignore this stock until next June, 2027. Let the management do their jobs until this company gets sold to a BP. We know that we have good science. Don’t let the stock price and naked shorts to kill you every day. GLTA!
2 · Reply
dubstep
dubstep Jul. 31 at 8:14 PM
$GALT Welp, that was a terrible week. At this point, all we can do is hope management provides something: • News • An update • Direction • A meaningful PR As the share price continues to slide, the one thing we can’t afford is more silence. Which is what we will likely get :( A question for everyone on this board: Why do you think the stock keeps dropping, and why does the market seem to have so little interest right now? I’m genuinely surprised. Based on where GALT is in the regulatory process, I would have expected a much stronger valuation. Clearly, the market is not pricing this company like a Phase 3 story. Is the market that spooked by the dilution and the convertibles? (I figured becasue it was delayed till a likely buy out the convertibles didn’t matter but I guess clearly they do.) Is the science mid? Is the biotech space not as hot or slowing down BP already went shopping? We have lost almost all the gains Any ideas the casue? Can’t just be shorts right
1 · Reply
Bobear12
Bobear12 Jul. 31 at 8:04 PM
$GALT ASH I use to get excited about the Monday morning opening now I dread it. Bo
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 31 at 8:02 PM
$GALT news pre market on Monday would be nice start to the month and icing on the cake!
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 31 at 7:59 PM
$GALT like I said sub 3 close...$GALT stay tuned
1 · Reply
Bobear12
Bobear12 Jul. 31 at 7:57 PM
$GALT have you ever thought that somebody might know something that we don’t. Bo?
0 · Reply
Bobear12
Bobear12 Jul. 31 at 7:54 PM
$GALT $2.97, $2.98, $2.99 it does really matters. For the Bulls on this board that have been day trading and picked up a .02 profit on a 1,000 shares you have added fuel for the Shorts. Are you really a Bull. I’ll leave that up to the true Bulls that have invested over the long haul. Bo
0 · Reply
JollyAcorn2021
JollyAcorn2021 Jul. 31 at 7:27 PM
$GALT For people who can see second level stuff; is there like a giant "wall of buying" today at $3 or something? And everybody spare me the "a REAL investor doesn't worry about the day to day price changes" etc. etc. etc ad nauseum. I, busy trying to grow my share count. You got yours. Let me do me. (wait.. that didn't sound right... lol) I need the shorts to bring it just a leeeeeetle bit lower before I can buy back and grow the count in a meaningful way. Or I hold a reduced position over the weekend and roll the dice they do it Monday. Aarrgh! decisions
4 · Reply
pitkineagle
pitkineagle Jul. 31 at 7:27 PM
$GALT Let’s all chill out.
0 · Reply
Bobear12
Bobear12 Jul. 31 at 6:52 PM
$GALT The fact that the FDA agreed to allow GALT a P3 study is evidences that belapectin has merits for liver disease. The fact of shorting, naked shorts etc. is a factor of how the stock can be manipulated. As someone point out that the stock market operates like a Casino. Depending on what kind of news is release will determine how the price will reacted. The only thing that could stop the Shorts from manipulating the price is a positive announcement. Obviously, the management team, including Richard are not ready to make an announce at this time. Why? My guess there are important details that must be finalized. That is only my speculation. As someone posted we as shareholders can’t make them release news. We can elect a new board, with instruction to hire a new management team. Is that what you would want to do at this time?? Bo
1 · Reply
BigTisBack
BigTisBack Jul. 31 at 6:33 PM
$GALT I'm not thrilled with the SP, but I do feel we land that partner. Thats my queue to sell! Probably land somewhere near $20 on that day. 6 months later the price will be right where it is now unless they get the rare unicorn of a BO.
1 · Reply
BigTisBack
BigTisBack Jul. 31 at 6:16 PM
$GALT I think it's perfectly fine if investors want to complain here. It's a message board not a scientific journal forum. Being upset at Galectin's management team makes more sense to me than getting upset at someone venting about the SP. We can't move the needle so its def not on us!
0 · Reply
JBRUN
JBRUN Jul. 31 at 5:52 PM
$GALT last day of the month, I believe news is coming in the first week of August, fingers crossed 🤞
1 · Reply
Bobear12
Bobear12 Jul. 31 at 5:28 PM
$GALT JellyCorn looks like another 300,000 volume day. U think that good or bad??Bo know
0 · Reply
Kilarck
Kilarck Jul. 31 at 5:25 PM
$GALT people on this board act like stock moves are grades from a teacher or material and not manipulation to screw retail holders funny! Wall Street is a rigged casino play appropriately. Know what you own.
0 · Reply
Bobear12
Bobear12 Jul. 31 at 5:25 PM
$GALT the only thing I hoped for was that ThomasLD was in an all day meeting. Bo
0 · Reply
JBRUN
JBRUN Jul. 31 at 4:49 PM
$GALT grabbed 100 more @3.00
0 · Reply